A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for Injection

NCT06198764 ↗

Phase 3 Unknown 80 enrolled Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

RandomizedParallel-groupOpen-labelTreatment

Summary

A clinical study to evaluate Colistimethate Sodium for Injection combination with Meropenem versus Coly-Mycin® M Parenteral combined with Meropenem in the treatment of Carbapenem resistant gram-negative bacteria infection. A total of 80 patients will be enrolled in the study.

Timeline

Start: 2023-07-06
Primary completion: 2026-03
Completion: 2026-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Coly Mycin M	Unknown	—	Intravenous
Background	Meropenem for Injection	Unknown	—	Intravenous

A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for Injection

Summary

Timeline

Drugs

Indications